Unit No:  [**Numeric Identifier 93031**] Admission Date: [**2187-4-16**]        Discharge Date: [**2187-4-19**]  Date of Birth:  [**2123-3-25**]        Sex:  M  Service:  Internal Medicine   HISTORY OF PRESENT ILLNESS:  The patient is a 64-year-old male with a past medical history of coronary artery disease, status post renal transplant and recurrent upper gastrointestinal bleed who presents with further gastrointestinal bleed and anemia.
The patient had a complicated course following his coronary artery bypass graft in [**1-/2187**] including multiple deep venous thromboses requiring anticoagulation and an upper gastrointestinal bleed from a duodenal ulcer while on anticoagulation.
He received three units of packed red blood cells with increase in his blood pressure to the 80s to 90s and increase in his hematocrit to 19.
The patient underwent esophagogastroduodenoscopy and an initially nonbleeding ulcer began bleeding after injection.
The patient had a systolic blood pressure in the 120s post procedure and was transferred to the [**Hospital6 256**] for further management.
Coronary artery disease status post coronary artery bypass    graft in [**1-/2187**] complicated by hemothorax.
Status post cadaveric renal transplant in [**2183**].
Allopurinol 100 mg q day.
Prednisone 5 mg q day.
Lasix 40 mg q day.
Norvasc 10 mg q day.
Hydrochlorothiazide 25 mg q day.
Rosiglitazone 4 mg q day.
Hydralazine 75 mg q.i.d.
Protonix 40 mg b.i.d.
Wellbutrin-SR 150 mg h.s.
Hectorol 2.5 mg q day.
Cyclosporin 100 mg q a.m., 75 mg q p.m. 15.
Lopressor 125 mg t.i.d.
PHYSICAL EXAMINATION:  VITAL SIGNS:  On admission, temperature 97.3, blood pressure 150-160/50-60, pulse 62, respiratory rate 18 with O2 saturation of 100 percent on two liters.
LABORATORY DATA:  On admission, sodium 141, potassium 4.2, chloride 118, bicarbonate 15, BUN 130, creatinine 4.0, glucose 135, white blood cell count 10, hematocrit 19.5, platelets 175, PTT 37.4, INR 1.2.
The    patient received three units of packed red blood cells and    his hematocrit increased from a level of 19 on admission    to a level of 27.4 on discharge.
The patient was    maintained on Protonix intravenously 40 mg b.i.d.
This was discussed at length with Mr. [**Known lastname **] who    understood the risks and benefits of the procedure and    preferred not to proceed with it at this time.
Allograft nephropathy/chronic renal insufficiency:  The    patient was followed throughout the hospitalization course    by the Renal team.
The    patient was continued on prednisone, ciclosporin and    ciclosporin levels were followed.
Diabetes mellitus:  The patient was continued on a regular    insulin sliding scale, as well as on a diabetic diet.
History of deep venous thrombosis:  Given the patient's    recent bleed, as well as prior complications on    anticoagulation, the patient was maintained on pneumatic    compression boots.
Gout:  The patient was restarted on allopurinol at a dose    of 100 mg p.o.
Coronary artery disease:  The patient was restarted on his    beta blocker regimen of metoprolol 25 mg b.i.d.
He was given a prescription of ampicillin to complete his ten day course for his urinary tract infection.
Right upper extremity and right lower extremity deep    venous thrombosis, status post inferior vena cava filter.
Ampicillin 500 mg b.i.d.
Prednisone 5 mg q day.
Insulin regular as directed.
Ciclosporin 50 mg q p.m. and 75 mg q a.m. 6.
Pantoprazole 40 mg q day.
Hydralazine 25 mg q.i.d.
Amlodipine 5 mg q day.
Metoprolol tartrate 25 mg t.i.d.
Wellbutrin 150 mg extended release h.s.
Tamsulosin 0.4 mg b.i.d.
Allopurinol 100 mg q day.
Bumetanide 1 mg q day.
Lorazepam 1 mg t.i.d.
